By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Verrica Pharmaceuticals Inc. insiders have been one-way buyers this past year: five people put roughly $18.2 million into the stock and nobody sold with their own money.
Biggest single buyer: Manning Paul B, Director, with roughly $11.7 million. Notably, at least one C-suite executive was among the buyers.
Quarter by quarter: Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters. Big money check: 43 institutions held VRCA as of Q2 2026, and funds were split between buying and selling.
Are insiders buying or selling VRCA stock?
In the last 12 months Verrica Pharmaceuticals Inc. insiders made open-market purchases worth about $18.2 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in VRCA?
The most recent open-market insider trade in VRCA was filed on 2026-08-18.
How many institutions own VRCA?
43 investment managers reported holding VRCA in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded VRCA?
No congressional trades in VRCA were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).